Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikita Bhalerao

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Advances in Cancer Research|February 1, 2023
Role of tumor cell sialylation in pancreatic cancer progressionMichael P Marciel, Barnita Haldar, Jihye Hwang, et al.
Glycobiology|December 15, 2020
Regulation of ST6GAL1 sialyltransferase expression in cancer cellsKaitlyn A Dorsett, Michael P Marciel, Jihye Hwang, et al.
The Journal of Biological Chemistry|November 5, 2020
Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cellsColleen M Britain, Nikita Bhalerao, Austin D Silva, et al.
Cell Reports|April 26, 2025
Mitochondrial Ca<sup>2+</sup> controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticityJillian S Weissenrieder, Jessica Peura, Usha Paudel, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Mitochondrial Ca<sup>2+</sup> controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticityJillian S Weissenrieder, Jessica Peura, Usha Paudel, et al.
Cancer Discovery|October 24, 2025
P21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapyLin Zhou, Kelly D DeMarco, Katherine C Murphy, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 InhibitorsMuhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Nature Medicine|November 29, 2025
Targeting of HIF2-driven cachexia in kidney cancerMuhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose <i>de novo</i> lipogenesisNikita Bhalerao, Yamini Ogoti, Jessica Peura, et al.
Nature Communications|June 19, 2026
Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancerChaitanya N Parikh, Kelly D DeMarco, Nikita Bhalerao, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Advances in Cancer Research|February 1, 2023
Role of tumor cell sialylation in pancreatic cancer progressionMichael P Marciel, Barnita Haldar, Jihye Hwang, et al.
Glycobiology|December 15, 2020
Regulation of ST6GAL1 sialyltransferase expression in cancer cellsKaitlyn A Dorsett, Michael P Marciel, Jihye Hwang, et al.
The Journal of Biological Chemistry|November 5, 2020
Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cellsColleen M Britain, Nikita Bhalerao, Austin D Silva, et al.
Cell Reports|April 26, 2025
Mitochondrial Ca<sup>2+</sup> controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticityJillian S Weissenrieder, Jessica Peura, Usha Paudel, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Mitochondrial Ca<sup>2+</sup> controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticityJillian S Weissenrieder, Jessica Peura, Usha Paudel, et al.
Cancer Discovery|October 24, 2025
P21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapyLin Zhou, Kelly D DeMarco, Katherine C Murphy, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 InhibitorsMuhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Nature Medicine|November 29, 2025
Targeting of HIF2-driven cachexia in kidney cancerMuhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose <i>de novo</i> lipogenesisNikita Bhalerao, Yamini Ogoti, Jessica Peura, et al.
Nature Communications|June 19, 2026
Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancerChaitanya N Parikh, Kelly D DeMarco, Nikita Bhalerao, et al.
Pageof 2